Logos Global Management LP Bio N Tech Se Transaction History
Logos Global Management LP
- $761 Million
- Q4 2024
A detailed history of Logos Global Management LP transactions in Bio N Tech Se stock. As of the latest transaction made, Logos Global Management LP holds 300,000 shares of BNTX stock, worth $33.9 Million. This represents 4.49% of its overall portfolio holdings.
Number of Shares
300,000Holding current value
$33.9 Million% of portfolio
4.49%Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$928 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$498 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$485 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$214 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$204 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...